AMI Organics Ltd.

AMIORG

Market Cap
₹4,492 Cr.
P/E
107.59

AMI Organics Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years but more due to rerating
ROE
ROE has decreased vs 10 year trend
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
14.02%
3yr Average
20.05%
5yr Average
22.61%
Net Profit Margin
Latest
13.5%
3yr Average
14.4%
5yr Average
12.88%
ROCE
Latest
18.97%
3yr Average
22.91%
5yr Average
27.03%
Debt to Equity
Latest
0.01
3yr Average
0.28
5yr Average
0.4
Market Share
50% (as of Mar 21)
4-Dihydroxy 5 Nitrobenzaldehyde - Market Share
locked Source
40% (as of Mar 21)
6-Methoxy Carbonyl-2-Oxindole-Fg Market Share
locked Source
88% (as of Mar 21)
Dichloropyrimidine Market Share
locked Source
60% (as of Mar 21)
Glycidyl Phthalimide Market Share
locked Source
75% (as of Mar 21)
Intermediate - Amino Acetaldehyde Dimethyl Acetal - Global Market Share
locked Source
45% (as of Mar 21)
Morpholin-3-One Market Share
locked Source
90% (as of Mar 21)
Piperazine - Market Share
locked Source
82% (as of Mar 21)
Pyridin-3-One Market Share
locked Source
35% (as of Mar 21)
Triemethyl Ortho Benzoate Market Share
locked Source
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Verticals

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up - Segment Wise

locked
Source
|
Latest
|
locked
Historic

API Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Peer Comparison
Company Filing
Show Previous Years
Discussions & Analysis
AMI Organics Ltd.
Ami Organics Ltd - Discussion with Management - Omkara Capital
View the discussion on ValuePickr
Deep Dive With Executive Chairman & MD, Naresh Patel - CNBC
DHANDHA: Ami Organics Ltd - PART 2 | Let's Talk Business - Omkara Capital
Why We Bought Ami Organics - Marcellus
AMI Organics - A Small Cap Stock in Super Investor Portfolios - SOIC
Deep Dive Into Ami Organics - Value Educator
timeline